Skip to content
PICO Portalanswers from OpenAlex

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis

PaperCitations, authors & open-access status

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis have?

PICO Portalcitation count

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis has 61 citations in the OpenAlex counts PICO Portal stores.

When was Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis published?

PICO Portalyear

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis has 2012 year in the PICO Portal index.

What is the open-access status of Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis?

PICO Portaloa status

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis has gold oa status in the PICO Portal index.

What is the DOI of Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis?

PICO Portaldoi

The DOI for Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis is on the source record.

What is the PMID of Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis?

PICO Portalpmid

The PMID for Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis is on the source record.

What is the OpenAlex record for Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis?

PICO Portalopenalex

The OpenAlex for Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial